# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-21-004295
Filing Date
2021-04-16
Accepted
2021-04-16 17:09:42
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | gtbp_10k.htm | 10-K | 1655030
2 | CERTIFICATE OF DESIGNATION | gtbp_ex42.htm | EX-4.2 | 44942
3 | CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF | gtbp_ex311.htm | EX-31.1 | 16350
4 | CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF | gtbp_ex312.htm | EX-31.2 | 16337
5 | CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE | gtbp_ex321.htm | EX-32.1 | 6804
6 | CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE | gtbp_ex322.htm | EX-32.2 | 6648
7 | IMAGE | img1.jpg | GRAPHIC | 16817
8 | IMAGE | img2.jpg | GRAPHIC | 24289
9 | IMAGE | img3.jpg | GRAPHIC | 27840
10 | IMAGE | img4.jpg | GRAPHIC | 13192
11 | IMAGE | img5.jpg | GRAPHIC | 28545
| Complete submission text file | 0001654954-21-004295.txt |  | 4155051

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL INSTANCE DOCUMENT | gtbp-20201231.xml | EX-101.INS | 477377
13 | XBRL TAXONOMY EXTENSION SCHEMA | gtbp-20201231.xsd | EX-101.SCH | 27652
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | gtbp-20201231_cal.xml | EX-101.CAL | 44757
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | gtbp-20201231_def.xml | EX-101.DEF | 75332
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | gtbp-20201231_lab.xml | EX-101.LAB | 199848
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | gtbp-20201231_pre.xml | EX-101.PRE | 168179

Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40023 | Film No.: 21832329
SIC: 2834 Pharmaceutical Preparations